Favipiravir

产品详情

Product Description
Favipiraviris a novel RNA polymerase inhibitor.It mainly inhibits virus proliferation by blocking the replication of viral nucleic acid. In the fight against ebola epidemic in 2014, a female nurse infected with ebola virus in France and a sick nurse in Spain were cured after taking familavir.
Favipiravir is a nucleoside antiviral drug, the mechanism of action has not been fully explained. The target is the viral
FUCTION
RNA-dependent RNA polymerase. After oral absorption, the drug was converted into a bioactive nucleoside triphosphate of Favipiravir, whose structure was similar to that of purine and could compete with purines for viral RNA polymerase. The nucleoside triphosphates of Favipiravir can also be inserted into viral RNA strands, inducing lethal mutations in the virus. Therefore, in terms of mechanism, Favipiravir has potential antiviral effect on various RNA viruses.
Favipiravir can be used for antiviral treatment of influenza a and b. Research shows that, in addition to influenza virus, the drug
Favipiraviris also showed good antiviral activity against a variety of RNA viruses, such as ebola virus, sand virus, bunya virus, rabies virus.
Factory supply Best purity 99% API USP/EP Favipiravir(T-705) CAS 259793-96-9 Leading GMP producer

Certificate of analysis